Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings
Christophe Fraser,1,*Christl A. Donnelly,1,*Simon Cauchemez,1William P. Hanage,1Maria D. Van Kerkhove,1T. Déirdre Hollingsworth,1Jamie Griffin,1Rebecca F. Baggaley,1Helen E. Jenkins,1Emily J. Lyons,1Thibaut Jombart,1Wes R. Hinsley,1Nicholas C. Grassly,1Francois Balloux,1Azra C. Ghani,1Neil M. Ferguson,1,Andrew Rambaut,2Oliver G. Pybus,3Hugo Lopez-Gatell,4Celia M. Alpuche-Aranda,5Ietza Bojorquez Chapela,4Ethel Palacios Zavala,4Dulce Ma. Espejo Guevara,6Francesco Checchi,7Erika Garcia,7Stephane Hugonnet,7Cathy Roth,7The WHO Rapid Pandemic Assessment Collaboration
A novel influenza A (H1N1) virus has spread rapidly across theglobe. Judging its pandemic potential is difficult with limiteddata, but nevertheless essential to inform appropriate healthresponses. By analyzing the outbreak in Mexico, early data oninternational spread, and viral genetic diversity, we make anearly assessment of transmissibility and severity. Our estimatessuggest that 23,000 (range 6000 to 32,000) individuals had beeninfected in Mexico by late April, giving an estimated case fatalityratio (CFR) of 0.4% (range: 0.3 to 1.8%) based on confirmedand suspected deaths reported to that time. In a community outbreakin the small community of La Gloria, Veracruz, no deaths wereattributed to infection, giving an upper 95% bound on CFR of0.6%. Thus, although substantial uncertainty remains, clinicalseverity appears less than that seen in the 1918 influenza pandemicbut comparable with that seen in the 1957 pandemic. Clinicalattack rates in children in La Gloria were twice that in adults(<15 years of age: 61%; 15 years: 29%). Three different epidemiologicalanalyses gave basic reproduction number (R0) estimates in therange of 1.4 to 1.6, whereas a genetic analysis gave a centralestimate of 1.2. This range of values is consistent with 14to 73 generations of human-to-human transmission having occurredin Mexico to late April. Transmissibility is therefore substantiallyhigher than that of seasonal flu, and comparable with lowerestimates of R0 obtained from previous influenza pandemics.
1 MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, Faculty of Medicine, Norfolk Place, London W2 1PG, UK. 2 Institute of Evolutionary Biology, University of Edinburgh, Ashworth Laboratories, Edinburgh EH9 3JT, UK. 3 Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK. 4 Directorate General of Epidemiology, FCO. De P. Miranda, 177 5th Floor, Mexico City, 01480, Mexico. 5 National Institute of Epidemiological Diagnosis and Reference, Prolongación Carpio No. 470 (3° piso), Col Santo Tomás, México City, C.P. 11340, Mexico. 6 Secretaría de Salud - Servicios de Salud de Veracruz Soconusco No. 36, Colonia Aguacatal, C.P. 910 Xalapa, Veracruz, México State. 7 World Health Organization.
* These authors contributed equally to this work.
All authors are members of this collaboration.
To whom correspondence should be addressed. E-mail: neil.ferguson{at}imperial.ac.uk
The editors suggest the following Related Resources on Science sites:
In Science Magazine
LETTERS
James M. McCaw, Jodie McVernon, Emma S. McBryde, and John D. Mathews (28 August 2009) Science325 (5944), 1071-a.
[DOI: 10.1126/science.325_1071a] |Full Text »|PDF »
LETTERS
Bev Paterson, David N. Durrheim, and Frank Tuyl (28 August 2009) Science325 (5944), 1071-b.
[DOI: 10.1126/science.325_1071b] |Full Text »|PDF »
LETTERS
Christopher E. Ormsby and Gustavo Reyes-Terán (28 August 2009) Science325 (5944), 1072-a.
[DOI: 10.1126/science.325_1072a] |Full Text »|PDF »
LETTERS
Christophe Fraser, Christl A. Donnelly, Simon Cauchemez, William P. Hanage, Maria D. van Kerkhove, T. Déirdre Hollingsworth, Jamie Griffin, Rebecca F. Baggaley, Helen E. Jenkins, Emily J. Lyons, Thibaut Jombart, Wes R. Hinsley, Nicholas C. Grassly, Francois Balloux, Azra C. Ghani, Andrew Rambaut, and Neil M. Ferguson (28 August 2009) Science325 (5944), 1072-b.
[DOI: 10.1126/science.325_1072b] |Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Modelling the impact of pandemic influenza A(H1N1) on UK paediatric intensive care demand.
(2009)
Arch. Dis. Child.
94, 962-964
Modelling mitigation strategies for pandemic (H1N1) 2009.
M. Z. Gojovic, B. Sander, D. Fisman, M. D. Krahn, and C. T. Bauch (2009)
Can. Med. Assoc. J.
181, 673-680
|Abstract »|Full Text »|PDF »
Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico.
G. Dominguez-Cherit, S. E. Lapinsky, A. E. Macias, R. Pinto, L. Espinosa-Perez, A. de la Torre, M. Poblano-Morales, J. A. Baltazar-Torres, E. Bautista, A. Martinez, et al. (2009)
JAMA
302, 1880-1887
|Abstract »|Full Text »|PDF »
Design and Validation of Real-Time Reverse Transcription-PCR Assays for Detection of Pandemic (H1N1) 2009 Virus.
K. Pabbaraju, S. Wong, A. A. Wong, G. D. Appleyard, L. Chui, X.-L. Pang, S. K. Yanow, K. Fonseca, B. E. Lee, J. D. Fox, et al. (2009)
J. Clin. Microbiol.
47, 3454-3460
|Abstract »|Full Text »|PDF »
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus.
Y. Yang, J. D. Sugimoto, M. E. Halloran, N. E. Basta, D. L. Chao, L. Matrajt, G. Potter, E. Kenah, and I. M. Longini Jr. (2009)
Science
326, 729-733
|Abstract »|Full Text »|PDF »
Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey.
J. T F Lau, N. C Y Yeung, K C Choi, M. Y M Cheng, H Y Tsui, and S. Griffiths (2009)
BMJ
339, b4164
|Abstract »|Full Text »|PDF »
Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey.
D. Marcelli, C. Marelli, and N. Richards (2009)
Nephrol. Dial. Transplant.
|Abstract »|Full Text »|PDF »
Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009.
N. Khazeni, D. W. Hutton, A. M. Garber, N. Hupert, and D. K. Owens (2009)
Ann Intern Med
|Abstract »|Full Text »
Influenza A (H1N1) pandemic: true or false alarm.
A. Hayward (2009)
J Epidemiol Community Health
63, 775-776
|Full Text »|PDF »
Effects of an Ongoing Epidemic on the Annual Influenza Vaccination Rate and Vaccination Timing Among the Medicare Elderly: 2000-2005.
B.-K. Yoo, M. Kasajima, K. Fiscella, N. M. Bennett, C. E. Phelps, and P. G. Szilagyi (2009)
Am J Public Health
99, S383-S388
|Abstract »|Full Text »|PDF »
Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
Rapid Method To Support Diagnosis of Swine Origin Influenza Virus Infection by Sequencing of Real-Time PCR Amplicons from Diagnostic Assays.
R. J. Hall, M. Peacey, Q. S. Huang, and P. E. Carter (2009)
J. Clin. Microbiol.
47, 3053-3054
|Full Text »|PDF »
Influenza A (H1N1) infections among healthcare workers: a cause for cautious optimism.
J. Sng, D. Koh, and G. Koh (2009)
Occup. Environ. Med.
66, 569-570
|Full Text »|PDF »
Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets.
V. J. Munster, E. de Wit, J. M. A. van den Brand, S. Herfst, E. J. A. Schrauwen, T. M. Bestebroer, D. van de Vijver, C. A. Boucher, M. Koopmans, G. F. Rimmelzwaan, et al. (2009)
Science
325, 481-483
|Abstract »|Full Text »|PDF »
Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice.
T. R. Maines, A. Jayaraman, J. A. Belser, D. A. Wadford, C. Pappas, H. Zeng, K. M. Gustin, M. B. Pearce, K. Viswanathan, Z. H. Shriver, et al. (2009)
Science
325, 484-487
|Abstract »|Full Text »|PDF »